These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7905831)
1. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Paul IA; Layer RT; Skolnick P; Nowak G Eur J Pharmacol; 1993 Nov; 247(3):305-11. PubMed ID: 7905831 [TBL] [Abstract][Full Text] [Related]
2. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620 [TBL] [Abstract][Full Text] [Related]
3. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain. Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727 [TBL] [Abstract][Full Text] [Related]
4. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Nowak G; Ordway GA; Paul IA Brain Res; 1995 Mar; 675(1-2):157-64. PubMed ID: 7796124 [TBL] [Abstract][Full Text] [Related]
5. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. Paul IA; Nowak G; Layer RT; Popik P; Skolnick P J Pharmacol Exp Ther; 1994 Apr; 269(1):95-102. PubMed ID: 8169857 [TBL] [Abstract][Full Text] [Related]
6. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists. Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987 [TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317 [TBL] [Abstract][Full Text] [Related]
8. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551. Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217 [TBL] [Abstract][Full Text] [Related]
9. A partial agonist model used in the allosteric modulation of the NMDA receptor. Robichon R; Randall PK; Leslie SW Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709 [TBL] [Abstract][Full Text] [Related]
10. A rapid filtration assay for the glycine binding site on the NMDA receptor in rat cortical membranes using [3H]dichlorokynurenic acid. Canton T; Doble A; Miquet JM; Jimonet P; Blanchard JC J Pharm Pharmacol; 1992 Oct; 44(10):812-6. PubMed ID: 1360506 [TBL] [Abstract][Full Text] [Related]
11. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression. Harkin A; Nally R; Kelly JP; Leonard BE J Neural Transm (Vienna); 2000; 107(10):1213-27. PubMed ID: 11129111 [TBL] [Abstract][Full Text] [Related]
12. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653. Oblin A; Schoemaker H Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987 [TBL] [Abstract][Full Text] [Related]
13. Calcium antagonists in the olfactory bulbectomy animal model of depression: effect on the cortical NMDA receptor complex. Nowak G Pol J Pharmacol; 1996; 48(2):137-43. PubMed ID: 9112643 [TBL] [Abstract][Full Text] [Related]
14. Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptor. Moroni F; Alesiani M; Galli A; Mori F; Pecorari R; Carlà V; Cherici G; Pellicciari R Eur J Pharmacol; 1991 Jun; 199(2):227-32. PubMed ID: 1720099 [TBL] [Abstract][Full Text] [Related]
15. Medium supplementation with zinc enables detection of imipramine-induced adaptation in glycine/NMDA receptors labeled with [3H]L-689,560. Dybała M; Maciag D; Cichy A; Pomierny-Chamioło L; Partyka A; Librowski T; Nowak G Pharmacol Rep; 2006; 58(5):753-7. PubMed ID: 17085868 [TBL] [Abstract][Full Text] [Related]
16. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916 [TBL] [Abstract][Full Text] [Related]
17. Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression. Nowak G; Ossowska G; Jopek R; Papp M Pol J Pharmacol; 1998; 50(4-5):365-9. PubMed ID: 10091723 [TBL] [Abstract][Full Text] [Related]
18. Chronic dosing with 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, modulates NMDA inhibition of muscarinic-coupled PI hydrolysis in rat cortical slices. Boje KM; Lakhman SS Neurochem Res; 1998 Sep; 23(9):1167-74. PubMed ID: 9712186 [TBL] [Abstract][Full Text] [Related]
19. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes. Mugnaini M; Antolini M; Corsi M; van Amsterdam FT J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880 [TBL] [Abstract][Full Text] [Related]
20. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors. Zhong J; Gribkoff VK; Molinoff PB Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]